ManishR.PatelMD

Clinical Trials

• Safety Study of X-82 in Patients With Advanced Solid Tumors Start of enrollment: 2011 Feb 01

  Completed

  Phase 1

• A Rollover Study for Patients Who Participated in Other Romidepsin Protocols Start of enrollment: 2011 May 01

  Completed

  Phase 2

• Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma Start of enrollment: 2011 Oct 01

  Completed

  Phase 1, Phase 2

• Study to Assess the Safety, Tolerability and Pharmacokinetics of Fimepinostat (CUDC-907) in Patients With Lymphoma Start of enrollment: 2012 Dec 01

  Completed

  Phase 1

• Phase I Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of BVD-523 in Patients With Advanced Malignancies Start of enrollment: 2013 Mar 01

  Completed

  Phase 1, Phase 2

• Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors Start of enrollment: 2013 Mar 29

  Completed

  Phase 1

• Phase I Dose Escalation Study of VS-4718 in Subjects With Metastatic Non-Hematologic Malignancies Start of enrollment: 2013 Jun 01

  Terminated

  Phase 1

• Rovalpituzumab Tesirine (SC16LD6.5) in Recurrent Small Cell Lung Cancer Start of enrollment: 2013 Jul 01

  Completed

  Phase 1, Phase 2

• Phase 1/2a Dose Escalation Study in Participants With CLL, SLL, or NHL Start of enrollment: 2013 Aug 30

  Completed

  Phase 1, Phase 2

• Study of the Glutaminase Inhibitor CB-839 in Solid Tumors Start of enrollment: 2014 Feb 01

  Completed

  Phase 1

• Study of Intravenous RXDX-107 in Patients With Solid Tumors Start of enrollment: 2015 Sep 01

  Terminated

  Phase 1

• A Phase 1/2 Study of MEDI4276 in Adults Subjects With Select HER2-expressing Advanced Solid Tumors. Start of enrollment: 2015 Sep 23

  Completed

  Phase 1

• Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With ER+ Breast Cancer Start of enrollment: 2016 Jun 29

  Completed

  Phase 1

• A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral Tomivosertib (eFT-508) in Subjects With Hematological Malignancies Start of enrollment: 2017 Feb 08

  Terminated

  Phase 1, Phase 2

• Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Activity of Defactinib in Combination With Avelumab in Epithelial Ovarian Cancer Start of enrollment: 2016 Oct 01

  Terminated

  Phase 1

• This Study Aims to Find the Best Dose of BI 907828 (Brigimadlin) in Patients With Different Types of Advanced Cancer (Solid Tumors) Start of enrollment: 2018 May 21

  Recruiting

  Phase 1

• A Study of Rivoceranib and Trifluridine/Tipiracil for Metastatic Colorectal Cancer (mCRC) Start of enrollment: 2019 Nov 18

  Terminated

  Phase 1

• A Study of BDTX-189, an Orally Available Allosteric ErbB Inhibitor, in Patients With Advanced Solid Tumors. Start of enrollment: 2019 Dec 19

  Terminated

  Phase 1, Phase 2

• Join now to see all